Renal Pelvis Cancer (DBCOND0041076)
Identifiers
- Synonyms
- Malignant neoplasm of renal pelvis / Malignant tumor of pelviureteric junction (disorder) / Malignant tumor of renal calyx (disorder) / Malignant tumor of renal pelvis (disorder) / Renal pelvis cancer NOS / Primary malignant neoplasm of renal pelvis (disorder)
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT06238479 A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06465069 A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT01844947 Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract treatment 1 completed NCT00661609 A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer No drug interventions treatment 2 completed NCT02665039 A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function treatment 2 completed NCT03662204 Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors No drug interventions Not Available Not Available completed NCT00902590 A Genotype-Phenotype Urothelial Cancer Registry No drug interventions Not Available Not Available active_not_recruiting NCT01236053 Cancer in Patients With Gabapentin (GPRD) Not Available Not Available completed NCT06427993 Urine DNA Methylation Detection for Hematuria Evaluation No drug interventions Not Available Not Available not_yet_recruiting NCT01138124 Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) Not Available Not Available completed NCT06469229 Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria No drug interventions Not Available Not Available not_yet_recruiting NCT01182168 Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies treatment 1 completed NCT02300610 Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer treatment 1 completed